Publications
Public Private Partnerships
- de Vrueh, R.L.A., de Vlieger, J.S.B., Orrling, K.M., van Rensen, J.M.L. From Innovator Result-driven to Multi-actor Impact-oriented Public–Private Partnerships: Integrating the Patient Perspective. In: Handbook of Experimental Pharmacology. Springer, Berlin, Heidelberg. DOI: 10.1007/164_2024_730 (2024).
- Josepine Fernow, Marie Olliver, William Couet, Sophie Lagrange, Meindert H. Lamers, Ole F. Olesen, Kristina Orrling, Michel Pieren, Derek J. Sloan, Juan José Vaquero, Timothy J. Miles & Anders Karlén. The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships. Nature Reviews Drug Discovery. DOI: 10.1038/d41573-024-00138-9 (2024)
(This publication can be freely accessed from the journal’s website between 23 September and 6 October 2024. To access the article after 6 October without a subscription, please go to the AMR Accelerator website.) - de Vrueh RLA, de Vlieger JSB and Crommelin DJA. Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare. Frontiers in Medicine 6, 114. (2019)
- de Vrueh, R. L., Crommelin, D. J. Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact. Pharmaceutical Research 34, 1985-99. (2017)
- de Vrueh, R. L., Awad, W., Stolk, A., Dijcks, F. A., Rijnders, T. W., & Janssen, J. W. Deal watch: Roles and strategies for health foundations in public-private partnerships. Nature Reviews Drug Discovery 13, 406-406. (2014)
- Awad, W., Stolk, A., Dijcks, F., & Vrueh de, R. Health Foundations Facilitate Translational Research Through Public-Private Partnerships. Leiden: TI Pharma. (2013) [PDF]
- Denee, T. R., Sneekes, A., Stolk, P., Juliens, A., Raaijmakers, J. A., Goldman, M., & Janssen, J. W. Measuring the value of public–private partnerships in the pharmaceutical sciences. Nature Reviews Drug Discovery 11, 419-419. (2012)